| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 01/12/2005 | EP1143992B1 Therapeutic compositions containing glutathione analogs |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | EP1030851B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564695A Pharmaceutical formulation |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1564680A Biodegradable polymeric nanocapsules and uses thereof |
| 01/12/2005 | CN1563370A Antiplasmin of Verticillium lecanii, preparation method and usage |
| 01/12/2005 | CN1563367A Defibrase modified by carbowax |
| 01/12/2005 | CN1562994A Producing technique for extracting extract products of amentoflavone |
| 01/12/2005 | CN1562358A Peroral enteric coated capsule of defibrase |
| 01/12/2005 | CN1562330A Haemostatic styptic for external use |
| 01/12/2005 | CN1562310A Soft capsule preparation of Tibet medicine 'unique taste' |
| 01/12/2005 | CN1562305A Chinese traditional medicine for treating cerebral thrombosis, preparation method and application |
| 01/12/2005 | CN1562288A Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases |
| 01/12/2005 | CN1562287A Health food of Chinese traditional medicine for promoting hematopoiesis and preparation method |
| 01/12/2005 | CN1562272A Medication for curing secondary anemia, iron deficiency anemia and preparation method |
| 01/12/2005 | CN1562271A Medication for treating primary disease of purpura haemorhagica and preparation method |
| 01/12/2005 | CN1562252A Hematogenesis oral liquid for ladies and preparation technique |
| 01/12/2005 | CN1562250A Hematogenesis agent for ladies and technique of preparing capsules |
| 01/12/2005 | CN1562242A Capsule of burnet for raising white cell and preparation method |
| 01/12/2005 | CN1562240A Dispersion tablet of burnet for raising white cell and preparation method |
| 01/12/2005 | CN1562216A Preparation of Chinese traditional medicine for curing cardiovascular and cerebrovascular disease and preparation method |
| 01/12/2005 | CN1562210A Burnet disintegration tablet of mouth and preparation method |
| 01/12/2005 | CN1562186A Preparation of Chinese traditional medicine for curing Illness of Cardiac cerebral ischemia and preparation method |
| 01/12/2005 | CN1562174A Injection emulsion of oil of zedoary turmeric, and preparation method |
| 01/12/2005 | CN1562158A Hemostatic |
| 01/12/2005 | CN1562128A Sugar-free granular agent for treating gynaopathy and its preparing method |
| 01/12/2005 | CN1562127A Hard capsule agent for treating gynaopathy and its preparing method |
| 01/12/2005 | CN1562126A Thin film coated medicinal tablet for treating gynaopathy and its producing method |
| 01/12/2005 | CN1562125A Medicinal oral liquid for treating gynaopathy and its producing method |
| 01/12/2005 | CN1562118A Chinese medicinal preparation for treating coronary heart disease, cerebral thrombus and cerebral infarct |
| 01/12/2005 | CN1562090A Haemotogenous agent blood tonic |
| 01/12/2005 | CN1562082A Ass-hide glue phosphotipid composition and its preparing method |
| 01/12/2005 | CN1562070A Medicine for treating leukopenia and its preparing method |
| 01/12/2005 | CN1562059A Chinese medicine composition for treating gynecopathy and its use |
| 01/12/2005 | CN1562056A Slow and control release preparation for thromus |
| 01/12/2005 | CN1562041A Alpostadil freeze-dried emulsion and its preparing method |
| 01/12/2005 | CN1562014A V emulsion nicotinate for injection and its preparing method |
| 01/12/2005 | CN1562006A Leucogen oral disintegration tablet and its preparing method |
| 01/12/2005 | CN1562001A Carbazochrome sodium sulfoate dripping pill and its preparing method |
| 01/12/2005 | CN1561998A Anti-platelet medicine and its use |
| 01/12/2005 | CN1561982A Bumetanide dripping pill and its preparing method |
| 01/12/2005 | CN1184313C Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1183966C Application of human urokininogenase in preparing medicine for preventing and treating cerebral infraction |
| 01/12/2005 | CN1183962C Preparation capable of mobilization of activity |
| 01/12/2005 | CN1183949C Medicine for treating thrombus disease |
| 01/12/2005 | CN1183928C Chinese medicinal powder for resisting thrombosis and its preparation method |
| 01/11/2005 | US6841701 Inhibitors for the blood-clotting factor Xa |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841568 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841545 Heat resistance; anticancer drug |
| 01/11/2005 | US6841534 For inhibiting blood coagulation |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |
| 01/11/2005 | US6841177 Pharmacological activities of curcuma longa extracts |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/06/2005 | WO2005001469A1 Method of acidic polysaccharide analysis and kit for the analysis |
| 01/06/2005 | WO2005000336A2 The use of caldag-gefi inhibitors as antithrombotic agents |
| 01/06/2005 | WO2004087646A3 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004073588A3 Diagnostics and therapeutics for diseases associated with g protein coupled receptor r35 (r35) |
| 01/06/2005 | WO2004071392A3 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | WO2004062684A3 Treatment of thrombocytopenia with inhibitors of pacap |
| 01/06/2005 | WO2004062657A8 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |
| 01/06/2005 | US20050004363 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004231 Method for inhibiting platelet aggregation |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004145 KW-3902 (8-(3-noradamantyl)-1,3-dipropylxanthine) as adenosine A1 receptor antagonist combined with at least one other diuretic |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050004103 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004082 Ether compounds |
| 01/06/2005 | US20050004037 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004021 Enzyme inhibitor for therapy of thrombosis, blood disorders |
| 01/06/2005 | US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders. |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050002986 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 01/05/2005 | EP1493810A1 DNA-based aptamers for human cathepsin G |
| 01/05/2005 | EP1493745A1 New crystalline and amorphous form of a triazolo(4,5-D)pyrimidine compound |